| INSULET CORP. DL -,001 |
| USA |
| Gesundheit |
| US45784P1012 / A0MQX8 |
| GOV (Frankfurt) / PODD (NASDAQ) |
| FRA:GOV, ETR:GOV, GOV:GR, NASDAQ:PODD |
| - |
| https://www.insulet.com/ |
|
Insulet Corporation is a medical device company specializing in insulin delivery technologies for people living with insulin‑dependent diabetes. The company focuses on its Omnipod platform, a family of tubeless, wearable, pod-based insulin manageme..
>Volltext.. |
| 10193.45 Mio. EUR |
| 10597.46 Mio. EUR |
| 2515.71 Mio. EUR |
| 542.62 Mio. EUR |
| 262.59 Mio. EUR |
| 3.74 EUR |
| 822.21 Mio. EUR |
| 416.61 Mio. EUR |
| 537.07 Mio. EUR |
| 0.7 |
| 23.53% |
| -29.5% |
| - |
| - |
| - |
| - |
| INSULET |
| 05.08.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|